Enochian Biosciences Inc ENOB Income Statement

Enochian biosciences inc (ENOB)

Income statement / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11
Revenues
-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	0	0	0	-	0	0	0	0	0	32	32	31	31	0	0	0	0	0	0	0	0
Cost of Goods Sold
-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenues
-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Goods Sold
-	-	-	-	-	-	-	-	-	-	-	-	0	0	5	5	26	71	136	279	322	295	266	139	111	109	0	0	0	-	-	-	-	-	-	-	-
Gross profit (Loss)
-	-	-	-	-	-	-	-	-	-	0	0	0	0	37	37	15	-28	-136	-279	-322	-295	-266	-137	-110	-76	0	0	0	-	-	-	-	-	-	-	-
Operating Expenses
General and administrative
7,078	7,543	8,888	8,271	7,747	7,775	4,863	3,899	3,147	1,336	1,017	933	1,167	1,256	1,229	1,229	1,150	1,265	1,601	1,636	1,691	1,644	996	1,019	737	586	587	330	202	32	33	40	29	34	0	0	0
Stock-Based Compensation Expense
-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Non-Cash and Stock-Based Compensation Expense
-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Non-Cash and Stock-Based Compensation Expense
-	-	-	-	-	-	-	-	-	-	-	626	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Research and development
3,874	2,297	2,524	2,498	2,118	1,525	956	616	527	405	199	62	236	455	719	804	2,089	2,004	1,727	1,625	151	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Depreciation and Amortization
-	-	-	-	-	-	-	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Depreciation and amortization
129	97	87	71	0	0	0	-	-	-	-	-	-	-	-	27	27	27	16	17	16	18	32	29	36	38	0	0	0	-	-	-	-	-	-	-	-
Consulting Expenses
-	-	0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Consulting Expenses
-	-	-	-	-	-	-	794	1,233	1,036	830	762	378	231	66	96	68	343	530	624	700	469	528	461	438	390	0	0	0	-	-	-	-	-	-	-	-
Total Operating Expense
11,200	10,056	11,619	10,990	9,063	9,616	6,516	5,329	5,793	2,906	2,173	2,400	2,423	2,585	2,669	2,158	3,334	3,642	3,875	3,903	2,560	2,133	2,204	2,158	1,860	1,662	0	0	0	-	-	-	-	-	-	-	-
LOSS FROM OPERATIONS
-11,200	-10,056	-11,619	-10,990	-9,063	-9,616	-6,516	-5,329	-5,793	-2,906	-2,173	-2,400	-2,423	-2,585	-2,631	-2,120	-3,319	-3,670	-4,011	-4,183	-2,882	-2,429	-2,470	-2,295	-1,970	-1,738	0	0	0	-	-	-	-	-	-	-	-
Other Income (Expense)
Change in fair value of contingent consideration
4,719	2,191	-10,483	-7,073	0	0	0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest expense
0	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Income (Expense)
-	-	-	-	-	-	-	-	4	8	10	11	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	84	68	269	400	546	546	325	160	0	0	0	-	0	0	-	-
Interest (expense)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Income (Expense) - Related Party
-	-	-	-	-	-	-	-	-166	20	12	15	11	8	5	2	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gain on forgiveness of debt
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	0	0	-	-	-	-	-	-	-	-	-
(Loss) gain on currency transactions
159	324	292	-26	-431	-507	-128	290	1,160	1,169	583	218	-405	-229	-19	-74	150	-514	-389	-356	-433	-40	11	101	119	19	0	0	0	-	-	-	-	-	-	-	-
Gain on settlement
0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest and other income
0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Income, Forgiveness of Debt
-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gain on derivative liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	175	0	0	0	-	-	-	-	-	-	-	-
Gain on Sale of Assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	0	-	-	-	-	-	-	-	-	-
Interest and Other Income
-	-	-	-	-	-	-	-	15	14	8	0	0	0	0	0	-6	0	5	5	12	5	0	0	0	0	0	0	0	-	-	-	-	-	-	-	-
Total Other Income (Expense)
5,053	2,693	-10,129	-7,026	-12,273	-11,955	-26	-1,094	1,337	1,154	569	192	-422	-241	-25	-77	147	-512	-410	-396	-493	-119	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Loss Before Income Taxes
-6,147	-7,363	-21,749	-18,016	-21,337	-21,572	-6,543	-6,423	-4,455	-1,751	-1,604	-2,207	0	0	0	-	-	-	-	-	-	-	-	-	-	0	-	-	-37	-32	-33	-40	-29	-34	0	0	0
Total Other Income (Expense)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	0	0	0	-	-	-	-	-	-	-	-
(Loss) Before Income Taxes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-3,171	-4,183	-4,421	-4,580	-3,388	-2,561	-1,570	-1,408	-1,150	-1,123	-1,124	-759	-426	-39	-43	0	-	0	0	-	-
Income Tax Benefit
-	-	0	-	-	-	-107	-111	-8	-18	-29	-64	-132	-152	-479	-462	-771	-737	-444	-418	-177	-177	-130	-132	0	0	0	0	0	0	0	0	0	0	0	0	0
LESS NET LOSS ATTRIBUTABLE TO NON-CONTROLLED INTEREST IN SUBSIDIARY
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-
NET LOSS
-6,147	-7,363	-21,749	-18,016	-21,236	-21,466	-6,436	-6,311	-4,447	-1,733	-1,575	-2,142	-2,713	-2,674	-2,178	-1,735	-2,399	-3,445	-3,976	-4,161	-3,198	-2,370	-1,426	-1,262	0	0	0	-	-426	-32	-33	-40	-29	-34	0	0	0
NET (LOSS)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	0	0	-	-	-	-	-	-	-	-
BASIC AND DILUTED LOSS PER SHARE
-0.03	-0.04	-0.09	0.05	-0.07	-0.45	-0.01	-0.07	-0.12	-0.08	-0.02	0.04	-0.03	-0.10	-0.08	-0.08	-0.02	-0.04	-0.04	-0.15	-0.13	-0.11	-0.07	-0.06	-0.06	0.00	-0.07	-0.06	-0.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - BASIC AND DILUTED
46,275	46,275	46,241	40,794	37,070	36,172	36,170	36,438	24,790	13,847	12,685	20,465	9,533	9,533	9,533	9,533	9,533	9,533	9,533	9,533	9,533	8,925	8,080	8,040	6,880	5,000	5,318	5,318	5,133	5,000	5,000	5,000	5,015	5,000	2,826	0	0